| abstract |
Topical administration of a cholinomimetic agent, such as pilocarpine, in combination with a cholinergic M 3 receptor antagonist, such as 4-diphenyl-acetoxy-N-methylpiperidine, to the eye of a mammal reduces intraocular pressure without the concommitant miotic effect that normally occurs with administration of a cholinomimetic agent along. |